Mozambican Alliance Towards Elimination of Malaria (MALTEM)
Mozambican Alliance Towards Elimination of Malaria
- Duration
- 01/09/2014 - 01/10/2019
- Coordinator
- Antoni Plasència
- Funded by
- Obra Social "la Caixa", Fundación Bill & Melinda Gates; Socios: CISM, Ministerio Salud Mozambique
Mozambique is among the ten countries with the highest burden of malaria worldwide, with a prevalence of infection in the population that ranges from 3% to more than 50% depending on the area. In 2016, an estimated 8 million cases and 14,000 malaria deaths occurred in the country. The main tools to control malaria include the use of mosquito nets impregnated with long-lasting insecticide, indoor spraying with insecticides and the diagnosis and adequate treatment of cases, and have been shown to achieve a significant decrease in transmission. However, these strategies are not sufficient to achieve malaria elimination.
Goals and Expected Outcomes
The objective of this project is to generate scientific evidence and provide technical, operational and economic support to assist the Mozambican National Malaria Control Program (NMCP) to design and evaluate new strategies to eliminate malaria in the south of the country (provinces of Maputo, Inhambane and Gaza). The project has been jointly financed by the Bill & Melinda Gates Foundation and the "la Caixa" Foundation for 5 years.
The project started at the end of 2014 with a pilot study in Magude, a district of about 52,000 inhabitants in the province of Maputo, with the aim of evaluating the feasibility, acceptability and impact of a package of interventions that consisted in:
- Universal coverage of indoor spraying with insecticides once a year
- Community engagement campaigns to increase the use of mosquito nets and the acceptability of the different interventions
- 2 rounds of mass administration of antimalarial drugs per year
In addition, a census was conducted and an entomological surveillance and epidemiological surveillance system (collection of the number of cases of malaria per month) were implemented to monitor and evaluate the impact of the interventions. Resistance studies (to the antimalarial used in the mass drug administration), prevalence surveys of malaria infection and cost-effectiveness analysis of the interventions were also carried out.
After two years of interventions, there has been a significant decrease in the incidence of malaria cases and a 71% decrease in the prevalence of infection in the district population, compared to 2014. These results suggest that the intervention package that was implemented accelerates progress towards malaria elimination, although it does not interrupt its transmission.
In order to continue evaluating interventions to maintain the gains achieved so far and eventually eliminate persisting malaria cases in Magude, a reactive case detection was implemented in the district in March of 2017. This system consists of detecting malaria cases, either at health centres or by community health workers, visiting the patient's house, and treating all members of the household (regardless of whether they test positive or negative with the rapid diagnostic test).
This intervention has managed to maintain low levels of malaria cases for another year while the team continues to analyse the results in order to understand the impact of each intervention and help tailor elimination strategies for Southern Mozambique.
The project, which also has a strong advocacy component, has been successful in socializing the elimination agenda to the point that it is now part of the country's national malaria strategy and of the political agenda, and a specific technical elimination working group has been created.
Project promoters
The Bill & Melinda Gates Foundation
Partners
Manhiça Health Research Centre (CISM)
Mozambique Ministry of Health (MISAU)
Other projects
See Past ProjectsNHEPACHA
New Tools for the Diagnosis and Evaluation of Chagas Disease
RTS,S Vaccine Immunology Study
Study of immune correlates of protection against malaria after vaccination with RTS,S/AS01E: a comprehensive immunological arm of a Phase III double-blind, randomized, controlled multi-center trial
Euroleish.net
Control of Leishmaniasis. From bench to bedside and community
GREPIMER
Grup de recerca en patología importada i malaties emergents i re-emergents
TESEO
New chemotherapy regimens and biomarkers for Chagas Disease
ASINTMAL
Unravelling Disease Tolerance and Host Resistance in Afebrile 'P. falciparum' Infections: a Prospective Study in Mozambican Adults
ADAM
Malaria mass and focal drug administration to advance malaria elimination in Mozambique: accelerating programmatic implementation and policy translation
MULTIPLY
MULTIple doses of IPTi Proposal: a Lifesaving high Yield intervention
Science4Pandemics
Citizens engagement digital platform for collective intelligence in pandemics
HIDDENVIVAX
Novel organ-on-a-chip technology to study extracellular vesicles-mediated cryptic infections in Plasmodium vivax malaria
Subclinical Infections in Children and Long Term Health Effects
Infection acquisition in early life and health outcomes in childhood - MARATO TV3
Herramienta innovadora de detección de enfermedades y vacunación a población inmigrante en riesgo en España
Project Code: PI21/00651
Impacto de las coinfecciones en el balance de respuestas de anticuerpos y linfocitos T helper a antígenos diana de inmunidad natural y vacunal frente a patógenos humanos prominentes
Project Code: PI20/00866
EpiGen
Building Scalable Pathogen Genomic Epidemiology in Ethiopia
MalTransc
Transcriptional regulation of adaptation and developmental decisions in malaria parasites: from epigenetic variation to directed transcriptional responses
BOHEMIA
Broad One Health Endectocide-based Malaria Intervention in Africa
RESPONSE
Mechanisms of the transcriptional responses to changes in the environment in the malaria parasite Plasmodium falciparum
VivaxEVTalk
Extracellular Vesicles as Intercellular Communicators and Biomarkers of Cryptic Erythrocytic Infections in Plasmodium vivax malaria
VaMonoS
Unravelling the heterogoneity and function of monocytes in vaccination and immunity to malaria
CLIMSOCTRYPBOL
Insight on climate and social participatory research for integral management of vectorborne zoonosis caused by Trypanosoma cruzi and Leishmania spp. in the Bolivian Gran Chaco.
SexMal
Social affairs and sex in P. falciparum: implications for malaria elimination
MENA Migrant Health
Transforming data collection and surveillance to drive migrant health research, care and policy
MESA
Sharing knowledge and catalyzing research towards a malaria-free world
GenMoz
P. falciparum genomic intelligence in Mozambique
SMART
Identifying Severe Malaria with a new Aptamer-based Rapid diagnostic Test